Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
September 30, 2026 -1.245M
June 30, 2026 -2.157M
March 31, 2026 -7.01M
December 31, 2025 -3.558M
September 30, 2025 -3.060M
June 30, 2025 -4.056M
March 31, 2025 -5.047M
December 31, 2024 -3.422M
September 30, 2024 -2.531M
June 30, 2024 -2.425M
March 31, 2024 -3.936M
December 31, 2023 -2.472M
September 30, 2023 -3.507M
June 30, 2023 -1.993M
March 31, 2023 -4.962M
December 31, 2022 -2.055M
September 30, 2022 -4.413M
June 30, 2022 -3.007M
March 31, 2022 -3.118M
December 31, 2021 -3.761M
September 30, 2021 -5.678M
June 30, 2021 -1.298M
March 31, 2021 -0.8256M
December 31, 2020 -1.024M
September 30, 2020 4.397M
Date Value
June 30, 2020 -1.658M
March 31, 2020 -5.147M
December 31, 2019 -5.186M
September 30, 2019 -6.595M
June 30, 2019 -10.58M
March 31, 2019 -7.262M
December 31, 2018 -7.658M
September 30, 2018 -10.74M
June 30, 2018 -9.280M
March 31, 2018 -10.26M
December 31, 2017 -7.172M
September 30, 2017 -6.432M
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015 -4.258M
September 30, 2015 -0.26M
June 30, 2015 -1.691M
March 31, 2015 -1.734M
December 31, 2014 -1.064M
September 30, 2014 -1.221M
June 30, 2014 -0.8869M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. -2.902M
Capricor Therapeutics, Inc. -35.69M
Ocugen, Inc. -15.74M
Cue Biopharma, Inc. -10.08M
Yarrow Bioscience, Inc. -89.96M